Top Markets
Coin of the day
Arch Biopartners Inc. Arch Biopartners Inc.

Arch Biopartners Inc.

ARCH
Classificação em ações #25412
Arch Biopartners Inc. is a biotechnology firm dedicated to devising... Arch Biopartners Inc. is a biotechnology firm dedicated to devising groundbreaking solutions for both medical and commercial applications. A significant focus for the company is the advancement of Metablok, a key therapeutic agent designed to address or avert dipeptidase-1 driven inflammation in critical organs such as the lungs, liver, and kidneys. This inflammatory response can lead to profound organ dysfunction or complete failure, particularly in conditions like sepsis and COVID-19. Moreover, Arch Biopartners is developing AB569, an experimental medication intended to combat antibiotic-resistant bacterial infections, primarily through topical application on wounds. Their innovative product pipeline also features Borg, a specialized peptide-solid surface interface developed to hinder biofilm formation and lessen material corrosion. Lastly, MetaMx involves synthetic compounds engineered to target the cells that initiate brain tumors and invasive glioma cells. The company's operations are based out of Toronto, Canada.
Preço da ação
$0.73393689
Última sincronização: 2026-08-20
Valor de mercado
$49.86M
Variação (1 dia)
-8.26%
Variação (1 ano)
-38.15%
País
CA
Negociar Arch Biopartners Inc. (ARCH)

Categoria

Histórico de preços das ações de Arch Biopartners Inc. (ARCH)
Preço de fecho mais alto: $0.80 em 2026-08-01

Preço de fecho mais baixo: $0.24 em 2010-05-01
Histórico de preços das ações da Arch Biopartners Inc. de 2010 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -23.16%
2025 -30.82%
2024 20.19%
2023 -48.03%
2022 -33.91%
2021 176.41%
2020 54.21%
2019 -26.71%
2018 185.93%
2017 8.76%
2016 42.45%
2015 -21.16%
2014 48.45%
2013 -6.69%
2012 -40.44%
2011 -46.45%
2010 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$539.14 35.65%
US
$1.04K 56.21%
NL
$118.42 -18.43%
AU
$761.87 8.65%
CH
$130.43 397.46%
US